Provided by Tiger Trade Technology Pte. Ltd.

Illumina

278.17
+13.605.14%
Post-market: 278.00-0.1700-0.06%19:59 EDT
Volume:1.90M
Turnover:519.19M
Market Cap:42.00B
PE:51.79
High:278.59
Open:268.21
Low:265.25
Close:264.57
52wk High:309.35
52wk Low:88.00
Shares:151.00M
Float Shares:149.05M
Volume Ratio:0.54
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.37
EPS(LYR):5.45
ROE:32.34%
ROA:8.67%
PB:14.80
PE(LYR):51.04

Loading ...

Movement Alert|Illumina Rises 5.19% in Regular Trading, AI Genomic Model Launch and Analyst Target Hikes Drive Gains

Market Focus
·
4 hours ago

Illumina to Announce Third Quarter 2026 Financial Results

Reuters
·
Yesterday

Illumina to Release Q3 2026 Results, Host Conference Call

Reuters
·
Yesterday

Illumina Launches New Genomic AI Model for Rare Disease Research

MT Newswires Live
·
Oct 08

Illumina Releases SpliceAI2, Says Model Identifies 17% More Disease-Relevant Splice Variants in Rare Disease Dataset

Reuters
·
Oct 08

Illumina Releases Spliceai2 to Help Advance Rare Disease Research

THOMSON REUTERS
·
Oct 08

Evercore ISI Adjusts Price Target on Illumina to $290 From $225

MT Newswires Live
·
Oct 07

Movement Alert|Illumina Intraday Rise 5.01%, RBC Raises Target to $310 on Clinical Sequencing Outlook

Market Focus
·
Oct 06

Barclays Adjusts Illumina Price Target to $200 From $160, Maintains Underweight Rating

MT Newswires Live
·
Oct 06

Alamar Biosciences Names Former GRAIL CEO Bob Ragusa to Board

Reuters
·
Oct 06

Illumina Inc Stock (ILMN) Moved Up by 7.85% on Oct 5: Drivers Behind the Movement

TradingKey
·
Oct 06

Movement Alert|Illumina Rises 5.24% in Regular Trading, RBC Ups Target to $310 on Clinical Growth Outlook

Market Focus
·
Oct 06

Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says

MT Newswires Live
·
Oct 05

Illumina is Maintained at Outperform by RBC Capital

Dow Jones
·
Oct 05

RBC Raises Price Target on Illumina to $310 From $230, Keeps Outperform Rating

MT Newswires Live
·
Oct 05

Illumina is Maintained at Buy by Guggenheim

Dow Jones
·
Oct 01

Illumina price target raised to $305 from $226 at Guggenheim

TIPRANKS
·
Oct 01

Guggenheim Adjusts Price Target on Illumina to $305 From $226, Keeps Buy Rating

MT Newswires Live
·
Oct 01

Illumina is Maintained at Outperform by Leerink Partners

Dow Jones
·
Sep 30

Leerink Partners Sticks to Their Buy Rating for Illumina (ILMN)

TIPRANKS
·
Sep 29